Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|February 8, 1997
Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative GroupA Mocroft, M Youle, J Morcinek, et al.HIV Medicine|December 12, 2001
Assessing the cost-effectiveness of HAART for adults with HIV in EnglandA H Miners, C A Sabin, P Trueman, et al.HIV Medicine|February 20, 2007
No association between HIV disease and its treatment and thyroid functionS Madge, C J Smith, F C Lampe, et al.AIDS (London, England)|April 1, 1990
The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumoniaM Bower, S E Barton, M R Nelson, et al.The Journal of Infection|March 1, 1989
Diagnosis, treatment and outcome of pneumonia in the acquired immune deficiency syndromeT D Gardner, M Youle, P J Hanson, et al.HIV Medicine|February 20, 2007
Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: relationships with genderS Shah, C J Smith, F Lampe, et al.HIV Medicine|February 27, 2008
An audit of viral load in one clinical population to describe features of viraemic patients on antiretroviral therapyS Madge, C J Smith, F Lampe, et al.HIV Medicine|February 21, 2009
Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse populationTw Mahungu, Cj Smith, F Turner, et al.Journal of Clinical Pharmacology|September 2, 1998
Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I/II trial and extended follow-up in patients infected with human immunodeficiency virusG J Moyle, M Youle, C Higgs, et al.Pageof 8